|

GB18 injection Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Shenzhen Kexing Pharmaceutical Co., Ltd.1

Indications

  • Cancer Cachexia Syndrome1
  • Cancer Cachexia1
  • Cancer Cachexia (CC)1
  • Cancer1

Other1 trial

To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GB18 Injection in Healthy Participants
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.